Evommune EVMN Cash Flow Statement (2024-2026)

NYSE EVMN
$5.18 -0.20 (-3.72%)
As of: Oct 21, 2026 · 3:59 PM EDT
Reported Financials

Evommune Quarterly Cash Flow Statement

Periods 8 quarters
Latest Jun 2026

Evommune reported cash from operations of -$20.32M and free cash flow of -$20.50M for the quarter ended Jun 2026, up 22.5% year over year. This cash flow statement covers 8 quarters of results from Sep 2024 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income -15.90M-20.73M-14.56M-13.57M-12.48M-28.27M-21.67M-32.25M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Dep. & Amort. 0.36M0.38M0.38M0.31M0.33M0.35M0.55M
Share-based CompensationStock Comp. 0.40M0.49M0.54M0.56M0.56M4.20M3.45M4.60M
Change in Working Capital
Change in Account PayablesChange Payables 2.85M-0.69M-3.90M-0.10M3.85M-3.75M0.98M
Change in Accured ExpensesChange Accured Exp. -0.14M-2.10M1.29M-0.67M4.30M-4.81M5.95M
Change in Other Operating AssetsOther Assets Change 0.71M3.96M1.45M-3.42M0.37M0.09M-0.94M
Change in Other Operating LiabilitiesOther Liabilities Change -0.20M-3.21M-0.21M-0.18M-0.14M-0.19M-0.34M
Other Working Capital ChangesOther WC Changes -0.91M-7.17M-1.66M3.24M-0.51M-0.28M0.60M
Cash from OperationsCash from Ops. -18.51M-23.90M-26.21M-9.64M-16.70M-27.50M-20.32M
Investing Activities
Capital ExpendituresCapex 0.13M0.10M0.08M0.18M
Change in Property, Plant and EquipmentChange in PP&E -0.13M-0.10M-0.08M-0.18M
Purchase of InvestmentsInvestments Purchased 44.58M38.78M160.40M108.78M17.64M
Sale and Maturity of InvestmentsInvestments Sold 11.50M13.50M18.00M15.00M37.60M23.50M49.12M
Cash from Investing ActivitiesCash from Investing -33.08M13.50M18.00M-23.91M-122.90M-85.36M31.29M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt RepaymentsLT Debt Repayment -0.08M0.10M0.09M0.27M-0.06M0.10M0.13M
Non-Current Debt 0.08M-0.10M-0.09M-0.27M0.06M-0.10M-0.13M
Net Debt Issuances and RepaymentsNet Debt Issuance 0.08M-0.10M-0.09M-0.27M0.06M-0.10M-0.13M
Change in Capital Stock
Common Stock IssuedStock Issued 0.01M0.00M0.00M157.28M117.20M0.67M
Net Shares Issued and RepurchasedNet Shares Issued 0.01M0.00M0.00M157.28M117.20M0.67M
Net Equity Issued and RepurchasedNet Equity Issued 0.01M0.00M0.00M157.28M117.20M0.67M
Other financing activitiesOther financing -0.14M-0.35M
Cash from Financing ActivitiesCash from Financing 49.70M-0.15M64.34M-0.27M156.85M117.11M0.53M
Additional items
Change in Cash -1.89M-10.55M56.13M-33.82M17.25M4.25M11.51M
Ending Cash Balance 18.35M16.46M5.91M62.05M28.23M45.48M49.73M61.24M
Free Cash FlowFCF -18.51M-23.90M-26.21M-9.77M-16.80M-27.59M-20.50M
Net Cash FlowNCF -1.89M-10.55M56.13M-33.82M17.25M4.25M11.51M
Interest Paid 0.01M0.00M0.00M0.00M

Evommune Cash Flow Statement API

Pull Evommune's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=EVMN&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY